Connor, Clark & Lunn Investment Management (CC&L)’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.2M Sell
2025
Q1
$6.36M Sell
2024
Q4
$9.12M Buy
2024
Q3
$1.22M Buy
2024
Q2
Sell
2024
Q1
$1.45M Buy
2022
Q3
Sell
2022
Q2
$235K Buy